Out-of-Sequence Signal 3 as a Mechanism for Virus-Induced Immune Suppression of CD8 T Cell Responses

1. von PirquetC (1908) Das verhalten der kutanen tuberkulin-reaktion wahrend der Masern. Dtsch Med Wochenschr 34 : 1297–1300.

2. MeyaardL (1992) Programmed death of T cells in HIV-1 infection. Science (New York, NY) 257 : 217–219.

3. MimsCA, WainwrightS (1968) The Immunodepressive Action of Lymphocytic Choriomeningitis Virus in Mice. J Immunol 101 : 717–724.

4. OsbornJE, BlazkovecAA, WalkerDL (1968) Immunosuppression during Acute Murine Cytomegalovirus Infection. J Immunol 100 : 835–844.

5. KantzlerGB, LauteriaSF, CusumanoCL, LeeJD, GangulyR, et al. (1974) Immunosuppression During Influenza Virus Infection. Infect Immun 10 : 996–1002.

6. WelshRM, SelinLK, RazviES (1995) Role of apoptosis in the regulation of virus-induced T cell responses, immune suppression, and memory. J Cell Biochem 59 : 135–142.

7. RouseBT, HorohovDW (1986) Immunosuppression in Viral Infections. Rev Infect Dis 8 : 850–873.

8. ZarozinskiCC, McNallyJM, LohmanBL, DanielsKA, WelshRM (2000) Bystander Sensitization to Activation-Induced Cell Death as a Mechanism of Virus-Induced Immune Suppression. J Virol 74 : 3650–3658.

9. RazviES, WelshRM (1993) Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol 67 : 5754–5765.

10. MathewA, KuraneI, GreenS, VaughnDW, KalayanaroojS, et al. (1999) Impaired T Cell Proliferation in Acute Dengue Infection. J Immunol 162 : 5609–5615.

11. ZunigaEI, LiouL-Y, MackL, MendozaM, OldstoneMBA (2008) Persistent Virus Infection Inhibits Type I Interferon Production by Plasmacytoid Dendritic Cells to Facilitate Opportunistic Infections. Cell Host Microbe 4 : 374–386.

12. Díaz-San SegundoF, Rodríguez-CalvoT, de AvilaA, SevillaN (2009) Immunosuppression during Acute Infection with Foot-and-Mouth Disease Virus in Swine Is Mediated by IL-10. PLoS ONE 4: e5659.

13. MarshallHD, UrbanSL, WelshRM (2011) Virus-Induced Transient Immune Suppression and the Inhibition of T Cell Proliferation by Type I Interferon. J Virol 85 : 5929–5939.

14. MescherMF, CurtsingerJM, AgarwalP, CaseyKA, GernerM, et al. (2006) Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev 211 : 81–92.

15. CurtsingerJM, MescherMF (2010) Inflammatory cytokines as a third signal for T cell activation. Curr Opin Immunol 22 : 333–340.

16. CurtsingerJM, JohnsonCM, MescherMF (2003) CD8 T Cell Clonal Expansion and Development of Effector Function Require Prolonged Exposure to Antigen, Costimulation, and Signal 3 Cytokine. J Immunol 171 : 5165–5171.

17. ObarJJ, LefrançoisL (2010) Early events governing memory CD8+ T-cell differentiation. Int Immunol 22 : 619–625.

18. XiaoZ, CaseyKA, JamesonSC, CurtsingerJM, MescherMF (2009) Programming for CD8 T Cell Memory Development Requires IL-12 or Type I IFN. J Immunol 182 : 2786–2794.

19. SikoraAG, JaffarzadN, HailemichaelY, GelbardA, StonierSW, et al. (2009) IFN-α Enhances Peptide Vaccine-Induced CD8+ T Cell Numbers, Effector Function, and Antitumor Activity. J Immunol 182 : 7398–7407.

20. CurtsingerJM, LinsDC, MescherMF (2003) Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells. J Exp Med 197 : 1141–1151.

21. CurtsingerJM, ValenzuelaJO, AgarwalP, LinsD, MescherMF (2005) Cutting Edge: Type I IFNs Provide a Third Signal to CD8 T Cells to Stimulate Clonal Expansion and Differentiation. J Immunol 174 : 4465–4469.

22. AgarwalP, RaghavanA, NandiwadaSL, CurtsingerJM, BohjanenPR, et al. (2009) Gene Regulation and Chromatin Remodeling by IL-12 and Type I IFN in Programming for CD8 T Cell Effector Function and Memory. J Immunol 183 : 1695–1704.

23. ThompsonLJ, KolumamGA, ThomasS, Murali-KrishnaK (2006) Innate Inflammatory Signals Induced by Various Pathogens Differentially Dictate the IFN-I Dependence of CD8 T Cells for Clonal Expansion and Memory Formation. J Immunol 177 : 1746–1754.

24. KepplerSJ, AicheleP (2011) Signal 3 requirement for memory CD8+ T-cell activation is determined by the infectious pathogen. Eur J Immunol 41 : 3176–3186.

25. KepplerSJ, RosenitsK, KoeglT, VucikujaS, AicheleP (2012) Signal 3 Cytokines as Modulators of Primary Immune Responses during Infections: The Interplay of Type I IFN and IL-12 in CD8 T Cell Responses. PLoS ONE 7: e40865.

26. PhamN-L, BadovinacV, HartyJ (2011) Differential role of “signal 3” inflammatory cytokines in regulating CD8 T cell expansion and differentiation in vivo. Front Immunol 2 : 4.

27. KolumamGA, ThomasS, ThompsonLJ, SprentJ, Murali-KrishnaK (2005) Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202 : 637–650.

28. AicheleP, UnsoeldH, KoschellaM, SchweierO, KalinkeU, et al. (2006) Cutting Edge: CD8 T Cells Specific for Lymphocytic Choriomeningitis Virus Require Type I IFN Receptor for Clonal Expansion. The Journal of Immunology 176 : 4525–4529.

29. KepplerSJ, TheilK, VucikujaS, AicheleP (2009) Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8+ T cells. Eur J Immunol 39 : 1774–1783.

30. ObarJJ, JellisonER, SheridanBS, BlairDA, PhamQ-M, et al. (2011) Pathogen-Induced Inflammatory Environment Controls Effector and Memory CD8+ T Cell Differentiation. J Immunol 187 : 4967–4978.

31. MitchellTC, HildemanD, KedlRM, TeagueTK, SchaeferBC, et al. (2001) Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat Immunol 2 : 397–402.

32. MitchellTC, TeagueTK, HildemanDA, BenderJ, ReesWA, et al. (2002) Stronger Correlation of bcl-3 than bcl-2, bcl-xL, Costimulation, or Antioxidants with Adjuvant-Induced T Cell Survival. Ann N Y Acad Sci 975 : 114–131.

33. ValenzuelaJO, HammerbeckCD, MescherMF (2005) Cutting Edge: Bcl-3 Up-Regulation by Signal 3 Cytokine (IL-12) Prolongs Survival of Antigen-Activated CD8 T Cells. J Immunol 174 : 600–604.

34. JoshiNS, CuiW, ChandeleA, LeeHK, UrsoDR, et al. (2007) Inflammation Directs Memory Precursor and Short-Lived Effector CD8+ T Cell Fates via the Graded Expression of T-bet Transcription Factor. Immunity 27 : 281–295.

35. WieselM, CrouseJ, BedenikovicG, SutherlandA, JollerN, et al. (2012) Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo. Eur J Immunol 42 : 320–329.

36. CurtsingerJM, LinsDC, JohnsonCM, MescherMF (2005) Signal 3 Tolerant CD8 T Cells Degranulate in Response to Antigen but Lack Granzyme B to Mediate Cytolysis. J Immunol 175 : 4392–4399.

37. Hervas-StubbsS, Perez-GraciaJL, RouzautA, SanmamedMF, Le BonA, et al. (2011) Direct Effects of Type I Interferons on Cells of the Immune System. Clin Cancer Res 17 : 2619–2627.

38. GilMP, SalomonR, LoutenJ, BironCA (2006) Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood 107 : 987–993.

39. NguyenKB, CousensLP, DoughtyLA, PienGC, DurbinJE, et al. (2000) Interferon [alpha]/[beta]-mediated inhibition and promotion of interferon [gamma]: STAT1 resolves a paradox. Nat Immunol 1 : 70–76.

40. GimenoR, LeeC-K, SchindlerC, LevyDE (2005) Stat1 and Stat2 but Not Stat3 Arbitrate Contradictory Growth Signals Elicited by Alpha/Beta Interferon in T Lymphocytes. Mol Cell Biol 25 : 5456–5465.

41. TanabeY, NishiboriT, SuL, ArduiniRM, BakerDP, et al. (2005) Cutting Edge: Role of STAT1, STAT3, and STAT5 in IFN-αβ Responses in T Lymphocytes. J Immunol 174 : 609–613.

42. NguyenKB, WatfordWT, SalomonR, HofmannSR, PienGC, et al. (2002) Critical Role for STAT4 Activation by Type 1 Interferons in the Interferon-γ Response to Viral Infection. Science 297 : 2063–2066.

43. GilMP, PloquinMJY, WatfordWT, LeeS-H, KimK, et al. (2012) Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function. Blood 120 : 3718–3728.

44. WelshRM, BahlK, MarshallHD, UrbanSL (2012) Type 1 Interferons and Antiviral CD8 T-Cell Responses. PLoS Pathog 8: e1002352.

45. MarshallHD, PrinceAL, BergLJ, WelshRM (2010) IFN-αβ and Self-MHC Divert CD8 T Cells into a Distinct Differentiation Pathway Characterized by Rapid Acquisition of Effector Functions. J Immunol 185 : 1419–1428.

46. CheonH, YangJ, George RStark (2011) The Functions of Signal Transducers and Activators of Transcriptions 1 and 3 as Cytokine-Inducible Proteins. J Interferon Cytokine Res 31 : 33–40.

47. YoshimuraA, SuzukiM, SakaguchiR, HanadaT, YasukawaH (2012) SOCS, inflammation and autoimmunity. Front Immunol 3 : 20.

48. AaronsonDS, HorvathCM (2002) A Road Map for Those Who Don't Know JAK-STAT. Science 296 : 1653–1655.

49. PiganisRAR, De WeerdNA, GouldJA, SchindlerCW, MansellA, et al. (2011) Suppressor of Cytokine Signaling (SOCS) 1 Inhibits Type I Interferon (IFN) Signaling via the Interferon α Receptor (IFNAR1)-associated Tyrosine Kinase Tyk2. J Biol Chem 286 : 33811–33818.

50. PalmerDC, RestifoNP Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol 30 : 592–602.

51. ZhengH, QianJ, VargheseB, BakerDP, FuchsS (2011) Ligand-Stimulated Downregulation of the Alpha Interferon Receptor: Role of Protein Kinase D2. Mol Cell Biol 31 : 710–720.

52. KaechSM, TanJoyce T, WherryJohn E, KoniecznyBogumila T, SurhCharles D, AhmedRafi (2003) Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 4 : 1191–1198.

53. PuauxA-L, CampanaudJ, SallesA, PrévilleX, TimmermanB, et al. (2006) A very rapid and simple assay based on trogocytosis to detect and measure specific T and B cell reactivity by flow cytometry. Eur J Immunol 36 : 779–788.

54. DaubeufS (2006) A simple trogocytosis-based method to detect, quantify, characterize and purify antigen-specific live lymphocytes by flow cytometry, via their capture of membrane fragments from antigen-presenting cells. Nat Protoc 1 : 2536–2542.

55. HudrisierD, RiondJ, MazarguilH, GairinJE, JolyE (2001) Cutting Edge: CTLs Rapidly Capture Membrane Fragments from Target Cells in a TCR Signaling-Dependent Manner. J Immunol 166 : 3645–3649.

56. HudrisierD, RiondJ, GaridouL, DuthoitC, JolyE (2005) T cell activation correlates with an increasedproportion of antigen among the materials acquiredfrom target cells. Eur J Immunol 35 : 2284–2294.

57. AkbarAN, BorthwickN, SalmonM, GombertW, BofillM, et al. (1993) The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 178 : 427–438.

58. MoutaftsiM, MehlAM, BorysiewiczLK, TabiZ (2002) Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 99 : 2913–2921.

59. WelshRM (2001) Immunology. Brief encounter. Nature (London) 411 : 541–542.

60. van StipdonkMJB, LemmensEE, SchoenbergerSP (2001) Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol 2 : 423–429.

61. KaechSM, AhmedR (2001) Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2 : 415–422.

62. MercadoR, VijhS, AllenSE, KerksiekK, PilipIM, et al. (2000) Early Programming of T Cell Populations Responding to Bacterial Infection. J Immunol 165 : 6833–6839.

63. WiedmannM, LiebertUG, OesenU, PorstH, WieseM, et al. (2000) Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology 31 : 230–234.

64. LaurenceJC (2005) Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus. Am J Med 118 : 75–83.

65. LeroyV (2002) The antibody response to hepatitis B virus vaccination is negatively influenced by the hepatitis C virus viral load in patients with chronic hepatitis C: a case-control study. Eur J Gastroenterol Hepatol 14 : 485–489.

66. Abu-ShakraM, PressJ, VarsanoN, LevyV, MendelsonE, et al. (2002) Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 29 : 2555–2557.

67. HolvastA, van AssenS, de HaanA, HuckriedeA, BenneCA, et al. (2009) Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. Arthritis Rheum 60 : 2438–2447.

68. WelshRM (1984) Natural killer cells and interferon. Crit Rev Immunol 5 : 55–93.

69. Le BonA, ThompsonC, KamphuisE, DurandV, RossmannC, et al. (2006) Cutting Edge: Enhancement of Antibody Responses Through Direct Stimulation of B and T Cells by Type I IFN. J Immunol 176 : 2074–2078.

70. WelshJR (1978) Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J Exp Med 148 : 163–181.

71. SchrierRD, RiceGPA, OldstoneMBA (1986) Suppression of Natural Killer Cell Activity and T Cell Proliferation by Fresh Isolates of Human Cytomegalovirus. J Infect Dis 153 : 1084–1091.

72. MitchellTC, ThompsonBS, TrentJO, CasellaCR (2002) A Short Domain within Bcl-3 Is Responsible for Its Lymphocyte Survival Activity. Ann N Y Acad Sci 975 : 132–147.

73. PircherH, BurkiKurt, LangRosemarie, HengartnerHans, ZinkernagelRolf M (1989) Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342 : 559–561.

74. MullerU, SteinhoffUlrich, ReisLuis FL, HemmiSilvio, PavlovicJovan, ZinkernagelRolf M (1994) Functional role of Type I and Type II interferons in antiviral defense. Science 264 : 1918–1921.

75. Welsh RM, Seedhom MO (2008) Lymphocytic Choriomeningitis Virus (LCMV): Propagation, Quantitation, and Storage. Curr Protoc Microbiol John Wiley & Sons, Inc.

76. YangHY, DundonPL, NahillSR, WelshRM (1989) Virus-induced polyclonal cytotoxic T lymphocyte stimulation. J Immunol 142 : 1710–1718.